Stocklytics Platform
Asset logo for symbol STAA
STAAR Surgical Co
STAA58
$42.50arrow_drop_down1.48%-$0.64
Asset logo for symbol STAA
STAA58

$42.50

arrow_drop_down1.48%

Performance History

Chart placeholder
Key Stats
Open$44.00
Prev. Close$44.23
EPS0.31
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range41.83
44.48
52 Week Range26.66
58.35
Ratios
EPS0.31

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$857.46
Perf. (24h)
arrow_drop_up1.00%$8.56
Market Cap$764.35B
Price$565.33
Perf. (24h)
arrow_drop_up0.17%$0.98
Market Cap$519.41B
Price$154.69
Perf. (24h)
arrow_drop_down0.46%-$0.73
Market Cap$374.04B
Price$125.77
Perf. (24h)
arrow_drop_up1.22%$1.52
Market Cap$314.70B

About STAAR Surgical Co (STAA)

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Mr. Thomas G. Frinzi
Headquarters
Lake Forest
Employees
882
Exchange
NASDAQ
add STAAR Surgical Co to watchlist

Keep an eye on STAAR Surgical Co

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is STAAR Surgical Co's (STAA) price per share?

The current price per share for STAAR Surgical Co (STAA) is $42.5. The stock has seen a price change of -$0.64 recently, indicating a -1.48% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for STAAR Surgical Co (STAA)?

For STAAR Surgical Co (STAA), the 52-week high is $58.35, which is 37.29% from the current price. The 52-week low is $26.66, the current price is 59.41% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is STAAR Surgical Co (STAA) a growth stock?

STAAR Surgical Co (STAA) has shown an average price growth of 0.41% over the past three years. It has received a score of 23 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying STAAR Surgical Co as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is STAAR Surgical Co (STAA) stock price performance year to date (YTD)?

As of the latest data, STAAR Surgical Co (STAA) has a year-to-date price change of 42.95%. Over the past month, the stock has experienced a price change of 5.96%. Over the last three months, the change has been -8.39%. Over the past six months, the figure is 46.4%. Looking at a longer horizon, the five-year price change stands at 36.88%.

help
Is STAAR Surgical Co (STAA) a profitable company?

STAAR Surgical Co (STAA) has a net income of $21.35M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 78.36% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -2.87% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $322.42M, with a revenue growth rate of 13.37%, providing insight into the company's sales performance and growth. The gross profit is $252.65M. Operating income is noted at $28.1M. Furthermore, the EBITDA is $32.5M.

help
What is the market capitalization of STAAR Surgical Co (STAA)?

STAAR Surgical Co (STAA) has a market capitalization of $2.12B. The average daily trading volume is 766.69K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level